R. Muse

Leveraging Real‐World Data for EMA Qualification of a Model‐Based Biomarker Tool to Optimize Type‐1 Diabetes Prevention Studies

J. Podichetty, K. Romero, Jackson K. Burton, 2022, Clinical pharmacology and therapeutics.

Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies

J. Podichetty, K. Romero, M. Haller, 2023, CPT: pharmacometrics & systems pharmacology.